MiR-23b expression is induced by tumor growth factors EGF, TNFα and HER2/ NEU (ERBB2), leading to BC tumor initiation and progression, via targeting Nischarin, which is a tumor suppressive gene53. The gene discussed is ERBB2; the disease is breast cancer.